Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy in the Treatment of Heart Failure with Reduced Ejection Fraction
Key result
Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy may improve ejection fraction and reverse symptoms in HFrEF, as reviewed in the 2016 ESC/HFA guidelines.
Population
Patients with heart failure and reduced ejection fraction (HFrEF)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Summarizes 2016 ESC/HFA ICD/CRT guidance in HFrEF; leaves open whether post-2016 evidence has shifted indications.
Structured PICO
P
Population
Patients with heart failure and reduced ejection fraction (HFrEF)
I
Intervention
Implantable Cardioverter-Defibrillators (ICD) and Cardiac Resynchronization Therapy (CRT)
This review summarizes the 2016 ESC/HFA guideline recommendations and evidence base for the use of ICD and CRT in patients with HFrEF.
Cite This Study
Spoletini et al. (2017) conducted a review in Heart failure with reduced ejection fraction (HFrEF). Implantable Cardioverter-Defibrillators (ICD) and Cardiac Resynchronization Therapy (CRT) was evaluated. Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy may improve ejection fraction and reverse symptoms in HFrEF, as reviewed in the 2016 ESC/HFA guidelines.